Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,128 across all filing types
Latest filing 2023-11-23 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
112年第3季財務報告書 — 202302_1707_AI1.pdf
Regulatory Filings
2023-11-23 Chinese
112年第3季財務報告書 — 202301_1707_AIA.pdf
Regulatory Filings
2023-11-23 Chinese
112年第3季財務報告書 — 202301_1707_AI1.pdf
Regulatory Filings
2023-11-23 Chinese
112年第3季財務報告書 — 202304_1707_AIC.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'Parent Company Only Financial Statements for the Years Ended December 31, 2023 and 2022 and Independent Auditors’ Report' and contains an Independent Auditors’ Report section. It includes detailed audit opinions, key audit matters, responsibilities of management and auditors, and extensive financial statements such as balance sheets with comparative figures for 2023 and 2022. The content is comprehensive, covering the full audit report and financial data for the fiscal year, which aligns with the characteristics of an Audit Report / Information filing. It is not merely an announcement or a summary but the full audit report with financial statements. Therefore, the document fits the Audit Report / Information (AR) category.
2023-11-23 Chinese
112年第3季財務報告書 — 202304_1707_AIA.pdf
Annual Report Classification · 100% confidence The document is titled 'Grape King Bio Ltd. and Subsidiaries Consolidated Financial Statements for the Years Ended December 31, 2023 and 2022 and Independent Auditors’ Report.' It contains detailed consolidated financial statements including balance sheets, statements of comprehensive income, changes in equity, cash flows, and notes. It also includes an Independent Auditors' Report with an opinion on the consolidated financial statements, audit basis, key audit matters, and auditors' responsibilities. The document references compliance with IFRS and local regulations, and the audit report is dated February 26, 2024. The length is about 15,000 characters, indicating a full report rather than a brief announcement. This matches the definition of an Annual Report (10-K) which covers the full financial performance and company activity for the fiscal year. Therefore, the document is classified as an Annual Report (10-K).
2023-11-23 Chinese
112年第3季財務報告書 — 202304_1707_AI3.pdf
Regulatory Filings
2023-11-23 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.